Transgenic carrot expressing fusion protein comprising M. tuberculosis antigens induces immune response in mice

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Permyakova, Natalia V ^a   Zagorskaya, Alla A ^a   Belavin, Pavel A ^a   Uvarova, Elena A ^a   Nosareva, Olesya V ^a   Nesterov, Andrey E ^a,b   Novikovskaya, Anna A ^a,b   Zav'Yalov, Evgeniy L ^a   Moshkin, Mikhail P ^a   Deineko, Elena V ^a  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

^b STATE RESEARCH CENTER OF VIROLOGY AND BIOTECHNOLOGY VECTOR   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

CULTURE FILTRATE PROTEIN 10; DELTAFERON; EARLY SECRETORY ANTIGENIC TARGET 6; HYBRID PROTEIN; INTERFERON; RECOMBINANT GAMMA INTERFERON; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; HLA ANTIGEN CLASS 2; MYCOBACTERIUM TUBERCULOSIS ANTIGENS; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CARROT; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXICITY; HUMORAL IMMUNITY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLANT TISSUE; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; GENETICS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MICROBIOLOGY; TRANSGENIC PLANT; TUBERCULOSIS;

AGROBACTERIUM; ANIMALIA; DAUCUS CAROTA; MUS; MYCOBACTERIUM TUBERCULOSIS;

ANIMALS; ANTIGENS, BACTERIAL; DAUCUS CAROTA; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNITY, INNATE; MICE; PLANTS, GENETICALLY MODIFIED; RECOMBINANT PROTEINS; TUBERCULOSIS;

EID: 84928494149     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/417565     Document Type: Article

References (48)

1. S. H. E. Kaufmann, "Fact and fiction in tuberculosis vaccine research: 10 years later, " The Lancet Infectious Diseases, vol. 11, no. 8, pp. 633-640, 2011.
2. L. P. Ormerod, R. J. Shaw, and D. M. Mitchell, "Tuberculosis in the UK, 1994: current issues and future trends, " Thorax, vol. 49, no. 11, pp. 1085-1089, 1994.
3. L. Dedieu, D. M. Floss, M. Mockey et al., "Expression and immunogenicity of the mycobacterial Ag85B/ESAT-6 antigens produced in transgenic plants by elastin-like peptide fusion strategy, " Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 274346, 14 pages, 2010.
4. M. P. Girard, U. Fruth, and M.-P. Kieny, "A review of vaccine research and development: tuberculosis, " Vaccine, vol. 23, no. 50, pp. 5725-5731, 2005.
5. P. Klucar, P. F. Barnes, Y. Kong et al., "Vaccination strategies to enhance local immunity and protection against Mycobacterium tuberculosis, " Vaccine, vol. 27, no. 12, pp. 1816-1824, 2009.
6. J.Dietrich, K.Weldingh, and P. Andersen, "Prospects for a novel vaccine against tuberculosis, " Veterinary Microbiology, vol. 112, no. 2-4, pp. 163-169, 2006.
7. P. S. Lakshmi, D. Verma, X. Yang, B. Lloyd, and H. Daniell, "Low cost tuberculosis vaccine antigens in capsules: expression in chloroplasts, bio-encapsulation, stability and functional evaluation in vitro, " PLoS ONE, vol. 8, no. 1, Article IDe54708, 2013.
8. A. S. Mustafa, "Development of new vaccines and diagnostic reagents against tuberculosis, " Molecular Immunology, vol. 39, no. 1-2, pp. 113-119, 2002.
9. M. I. de Jonge, G. Pehau-Arnaudet, M.M. Fretz et al., "ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity, " Journal of Bacteriology, vol. 189, no. 16, pp. 6028-6034, 2007.
10. R. Simeone, D. Bottai, and R. Brosch, "ESX/type VII secretion systems and their role in host-pathogen interaction, " Current Opinion in Microbiology, vol. 12, no. 1, pp. 4-10, 2009.
11. R. L. V. Skj?, T. Oettinger, I. Rosenkrands et al., "Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens, " Infection and Immunity, vol. 68, no. 1, pp. 214-220, 2000.
12. R. E. Soria-Guerra, L. Moreno-Fierros, and S. Rosales-Mendoza, "Two decades of plant-based candidate vaccines: a review of the chimeric protein approaches, " Plant Cell Reports, vol. 30, no. 8, pp. 1367-1382, 2011.
13. P. N.Miroshnikov and P. N. Lebedev, "Development of medicinal product deltaferon based on analog of recombinant human interferon-gamma, " Bulletin of Biotechnology and Physicochemical Biology, vol. 2, no. 2, pp. 5-10, 2006 (Russian).
14. V. I. Masicheva, N. M. Poustoshilova, and E. D. Danilenko, "Development of drugs based on genetically engineered cytokines, "Medical Immunology, vol. 3, no. 3, pp. 369-378, 2001.
15. S. I. Tat'kov, O. Y. Smirnova, R. Y. Tsivkovskii et al., "Mutant human gamma-interferon with a truncated C-terminus and its properties, " Doklady Biochemistry, vol. 372, no. 1-6, pp. 112-114, 2000.
16. S. Sereinig, M. Stukova, N. Zabolotnyh et al., "Influenza virus NS vectors expressing the Mycobacterium tuberculosis ESAT-6 protein induce CD4+ Th1 immune response and protect animals against tuberculosis challenge, " Clinical and Vaccine Immunology, vol. 13, no. 8, pp. 898-904, 2006.
17. J. A. Triccas, "Recombinant BCG as a vaccine vehicle to protect against tuberculosis, " Bioengineered Bugs, vol. 1, no. 2, pp. 110-115, 2010.
18. B. Hamasur, M. Haile, A. Pawlowski et al., "Mycobacterium tuberculosis arabinomannan-protein conjugates protect against tuberculosis, " Vaccine, vol. 21, no. 25-26, pp. 4081-4093, 2003.
19. M. M. Rigano, S. Dreitz, A.-P. Kipnis, A. A. Izzo, and A. M. Walmsley, "Oral immunogenicity of a plant-made, subunit, tuberculosis vaccine, " Vaccine, vol. 24, no. 5, pp. 691-695, 2006.
20. Y. L. Dorokhov, A. A. Sheveleva, O. Y. Frolova et al., "Superexpression of tuberculosis antigens in plant leaves, " Tuberculosis, vol. 87, no. 3, pp. 218-224, 2007.
21. E. A. Uvarova, P. A. Belavin, N. V. Permyakova et al., "Oral immunogenicity of plant-made Mycobacterium tuberculosis ESAT6 and CFP10, " BioMed Research International, vol. 2013, Article ID 316304, 8 pages, 2013.
22. J. T. van Dissel, S. M. Arend, C. Prins et al., "Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in nave human volunteers, " Vaccine, vol. 28, no. 20, pp. 3571-3581, 2010.
23. E. Yakushenko, J. Lopatnikova, E. Khrapov et al., "Use of transgenic carrot plants producing human interleukin-18 for modulation of mouse immune response, " in New Research on Biotechnology in Biology and Medicine, A. M. Egorov and G. Zaikov, Eds., chapter 10, pp. 97-107, Nova Science Publishers, New York, NY, USA, 2006.
24. S. H. Kaufmann, C. M. Ewing, and J. H. Shaper, "The erasable Western blot, " Analytical Biochemistry, vol. 161, no. 1, pp. 89-95, 1987.
25. M. M. Bradford, "A rapid and sensitive method for the quantitation ofmicrogram quantities of protein utilizing the principle of protein dye binding, " Analytical Biochemistry, vol. 72, no. 1-2, pp. 248-254, 1976.
26. S. Tat'kov, Y. Tumanov, O. Nosareva et al., "Use of recombinant species-specific M. tuberculosis proteins for serological diagnosing of the infection, " Epidemiology and Vaccine Prophylaxis, vol. 29, no. 4, pp. 42-47, 2006 (Russian).
27. P. Tijssen, Practice and Theory of Enzyme Immunoassays, Elsevier BV, Amsterdam, The Netherlands, 1985.
28. D. Gerlier and N. Thomasset, "Use of MTT colorimetric assay to measure cell activation, " Journal of Immunological Methods, vol. 94, no. 1-2, pp. 57-63, 1986.
29. V. Yusibov, S. J. Streatfield, and N. Kushnir, "Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond, " Human Vaccines, vol. 7, no. 3, pp. 313-321, 2011.
30. J. Kaufman and N. Kalaitzandonakes, "The economic potential of plant-made pharmaceuticals in the manufacture of biologic pharmaceuticals, " Journal of Commercial Biotechnology, vol. 17, no. 2, pp. 173-182, 2011.
31. K.-C. Kwon, D. Verma, N. D. Singh, R. Herzog, and H. Daniell, "Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells, " Advanced Drug Delivery Reviews, vol. 65, no. 6, pp. 782-799, 2013.
32. P. N. Desai, N. Shrivastava, and H. Padh, "Production of heterologous proteins in plants: strategies for optimal expression, " Biotechnology Advances, vol. 28, no. 4, pp. 427-435, 2010.
33. P. Maliga and R. Bock, "Plastid biotechnology: food, fuel, and medicine for the 21st century, " Plant Physiology, vol. 155, no. 4, pp. 1501-1510, 2011.
34. A. O. Viacheslavova, O. N. Mustafaev, A. A. Tiurin et al., "Set of module vectors for stable or transient expression of heterologous genes in plants, " Genetika, vol. 48, no. 9, pp. 1046-1056, 2012.
35. B.Nagels, K.Weterings, N. Callewaert, andE. J.M. vanDamme, "Production of plant made pharmaceuticals: from plant host to functional protein, " Critical Reviews in Plant Sciences, vol. 31, no. 2, pp. 148-180, 2012.
36. D. E.Webster and M. C. Thomas, "Post-translational modification of plant-made foreign proteins; glycosylation and beyond, " Biotechnology Advances, vol. 30, no. 2, pp. 410-418, 2012.
37. F. Fauser, N. Roth, M. Pacher et al., "In planta gene targeting, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 19, pp. 7535-7540, 2012.
38. M. S. Antunes, J. J. Smith, D. Jantz, and J. I.Medford, "Targeted DNA excision in Arabidopsis by a re-engineered homing endonuclease, " BMC Biotechnology, vol. 12, article 86, 2012.
39. R. K. Salyaev, M. M. Rigano, and N. I. Rekoslavskaya, "Development of plant-based mucosal vaccines against widespread infectious diseases, " Expert Review of Vaccines, vol. 9, no. 8, pp. 937-946, 2010.
40. N. A. Marveeva, M. I. Vasilenko, A. M. Shakhovski, and N. V. Kuchuk, "Agrobacterium-mediated transformation of lettuce (Lactuca sativa L.) with vectors bearing genes of bacterial antigenes fromMycobacterium tuberculosis, " Cytology and Genetics, vol. 43, no. 2, pp. 27-32, 2009.
41. N. A. Matvieieva, O. M. Kishchenko, A. O. Potrochov, A. M. Shakhovsky, and M. V. Kuchuk, "Regeneration of transgenic plants from hairy roots of Cichorium intybus L. var. Foliosum Hegi, " Cytology and Genetics, vol. 45, no. 5, pp. 277-281, 2011.
42. M. M. Rigano, M. L. Alvarez, J. Pinkhasov et al., "Production of a fusion protein consisting of the enterotoxigenic Escherichia coli heat-labile toxin B subunit and a tuberculosis antigen in Arabidopsis thaliana, " Plant Cell Reports, vol. 22, no. 7, pp. 502-508, 2004.
43. A. G. L?ossl and M. T. Waheed, "Chloroplast-derived vaccines against human diseases: achievements, challenges and scopes, " Plant Biotechnology Journal, vol. 9, no. 5, pp. 527-539, 2011.
44. E. A. Tydeman, M. L. Parker, R.M. Faulks et al., "Effect of carrot (Daucus carota) microstructure on carotene bioaccessibility in the upper gastrointestinal tract. 2. in vivo digestions, " Journal of Agricultural and Food Chemistry, vol. 58, no. 17, pp. 9855-9860, 2010.
45. L. Lemmens, S. van Buggenhout, A. M. van Loey, and M. E. Hendrickx, "Particle size reduction leading to cell wall rupture is more important for the -carotene bioaccessibility of raw compared to thermally processed carrots, " Journal of Agricultural and Food Chemistry, vol. 58, no. 24, pp. 12769-12776, 2010.
46. F. C. Minion, S. A. Menon, G. G. Mahairas, and M. J. Wannemuehler, "Enhanced murine antigen-specific gamma interferon and immunoglobulin G2a responses by usingmycobacterial ESAT-6 sequences in DNA vaccines, " Infection and Immunity, vol. 71, no. 4, pp. 2239-2243, 2003.
47. J.-S. Kim, W. S. Kim, H.-G. Choi et al., "Mycobacterium tuberculosis RpfB drives Th1-type T cell immunity via a TLR4-dependent activation of dendritic cells, " Journal of Leukocyte Biology, vol. 94, no. 4, pp. 733-749, 2013.
48. R. Fischer, S. Schillberg, S. Hellwig, R. M. Twyman, and J. Drossard, "GMP issues for recombinant plant-derived pharmaceutical proteins, " Biotechnology Advances, vol. 30, no. 2, pp. 434-439, 2012.